Zobrazeno 1 - 10
of 14
pro vyhledávání: '"Michaela Mayerová"'
Autor:
Marie Obdržálková, Libor Ustohal, Nataša Hlaváčová, Michaela Mayerová, Eva Češková, Tomáš Kašpárek, Daniela Ježová
Publikováno v:
Heliyon, Vol 9, Iss 10, Pp e21173- (2023)
The aim of this pilot study was to find whether the dysregulation of neuroendocrine biomarker signaling pathways in the first episode of non-affective psychosis is a predictive factor of treatment outcome. Patients with the first episode of non-affec
Externí odkaz:
https://doaj.org/article/95ff7287b37c46b7a5485167be799fed
Autor:
Michaela Mayerová, Libor Ustohal
Publikováno v:
Klinická farmakologie a farmacie. 36:150-155
Autor:
Michaela Mayerová, Libor Ustohal
Publikováno v:
Psychiatrie pro praxi. 23:144-149
Publikováno v:
Journal of Clinical Psychopharmacology. 43:186-187
Autor:
Hana Crhova, Marie Obdrzalkova, Libor Ustohal, Eva Češková, Hana Kučerová, Tomáš Kašpárek, Katerina Horska, Michaela Mayerová
Publikováno v:
International Journal of Psychiatry in Clinical Practice. 26:213-216
Patients with schizophrenia are at higher risk of cardiovascular (CVS) related mortality. Close attention is being paid to the clinical utility of readily available CVS markers.A pilot one-year longitudinal study in inpatients with first-episode psyc
Publikováno v:
Neuropsychiatric Disease and Treatment
Introduction Therapeutic drug monitoring (TDM) of clozapine is a very useful method for verifying both the correct intake and the interindividual variability of its metabolism, thereby avoiding the risk of toxicity. The purposes of this paper were to
Publikováno v:
Brain Stimulation, Vol 14, Iss 6, Pp 1686-(2021)
Publikováno v:
Journal of psychiatric research. 104
We have previously shown that patients with severe depressive episode exhibit higher aldosterone concentrations compared to those with moderate depressive episode. The present study was undertaken to test the hypothesis that circulating concentration
Publikováno v:
Neuropsychiatric Disease and Treatment. 15:655-656
Publikováno v:
Journal of Clinical Psychopharmacology. 36:181-183
Olanzapine, an atypical antipsychotic,has been considered one of the most efficient antipsychotic drugs, and it is the most frequently prescribed. It is categorized as a multiacting receptor targeted antipsychotic. The most significant adverse effect